Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin in Chronic Heart Failure
NCT04438213Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Mar 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ertugliflozin in heart failure (HF), sponsored by Yale University. Started Mar 2021; status: recruiting.
02
Drugs
ertugliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04438213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438213.